Journal of Marine Science: Research & Development
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Malaria is one of the world's top killer diseases, especially for the young children. Malaria has remained a major threat to
public health and economic development in the tropical and subtropical regions of the world. Attempts to control or
completely eradicate the disease have failed massively even with well-known resistance drugs for the malaria parasite and to
insecticides for the vector, the situation has become life-defying. Though there are collaborative energy both at international,
national and individual level to fight the disease by developing vaccines and new drugs but none have produced any permanent
result yet. In the field of science, the education about understanding the disease has recorded a tremendous progress.
After HIV/AIDS, malaria is the second leading cause of death in Africa. It is believe that nearly 1 in every 5 deaths among
kids in Africa is as a result of malaria. In my country Nigeria, malaria is a major public health problem where it accounts for cases
and deaths than any country world over. About 97% of my country's population is at risk for malaria because of their location. It
is only 3% of Nigeria's population live in the malaria free zones. Malaria alone accounts for more than 300,000 deaths each year
in Nigeria. This estimate is well above the 215,000 deaths each year from HIV/AIDS. If the above accounts for Nigeria alone how
about other 29 Sub-Saharan African countries which together accounts for 90% of the world wide malaria deaths?
The vaccine, which has been promised to be 'just round the corner' for many years, remains elusive. It is important to ask why
this is so, when effective vaccines exist for many other infectious diseases. What are the reasons for the slow rate of progress, and
what has been learned from the first clinical trials of candidate malaria vaccines? What are the remaining challenges, and what
strategies can be pursued to address them? The remaining major challenge is poverty. About 70% of Nigeria population lives in
poverty. Should any permanent remedy be found any time soon, these Sub-Saharan African countries like Nigeria should be the
starting point in the fight to eliminating malaria!
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals